[Treatment of virus diseases].
D000547:Amantadine / Q000627:therapeutic use*; D000700:Analgesics / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use*; D001645:Biguanides / Q000627:therapeutic use*; D006566:Herpesviridae Infections / Q000517:prevention & control; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007065:Idoxuridine / Q000627:therapeutic use*; D007251:Influenza, Human / Q000517:prevention & control; D051379:Mice; D008826:Microbial Sensitivity Tests; D012141:Respiratory Tract Infections / Q000517:prevention & control; D012899:Smallpox / Q000517:prevention & control; D013882:Thiosemicarbazones / Q000627:therapeutic use*; D014777:Virus Diseases / Q000188:drug therapy*; D014779:Virus Replication; D014780:Viruses / Q000187:drug effects / Q000254:growth & development; D005719:gamma-Globulins / Q000627:therapeutic use
D000700:Analgesics; D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D001645:Biguanides; D006634:Histamine H1 Antagonists; D013882:Thiosemicarbazones; D005719:gamma-Globulins; D000547:Amantadine; D007065:Idoxuridine
Therapie der Viruskrankheiten.